EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis

Gopinath Prakasam, Akhilesh Mishra, Alana Christie, Jeffrey Miyata, Deyssy Carrillo, Vanina T Tcheuyap, Hui Ye, Quyen N Do, Yunguan Wang, Oscar Reig Torras, Ramesh Butti, Hua Zhong und 12 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci170559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Gopinath Prakasam und 23 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Cancer Program, Simmons Comprehensive Cancer Center. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Translocation renal cell carcinoma (tRCC) most commonly involves an ASPSCR1-TFE3 fusion, but molecular mechanisms remain elusive and animal models are lacking. Here, we show that human ASPSCR1-TFE3 driven by Pax8-Cre (a credentialed clear cell RCC driver) disrupted nephrogenesis and glomerular development, causing neonatal death, while the clear cell RCC failed driver, Sglt2-Cre, induced aggressive tRCC (as well as alveolar soft part sarcoma) with complete penetrance and short latency. However, in both contexts, ASPSCR1-TFE3 led to characteristic morphological cellular changes, loss of epithelial markers, and an epithelial-mesenchymal transition. Electron microscopy of tRCC tumors showed lysosome expansion, and functional studies revealed simultaneous activation of autophagy and mTORC1 pathways. Comparative genomic analyses encompassing an institutional human tRCC cohort (including a hitherto unreported SFPQ-TFEB fusion) and a variety of tumorgraft models ( ASPSCR1-TFE3 , PRCC-TFE3 , SFPQ-TFE3 , RBM10-TFE3 , and MALAT1-TFEB ) disclosed significant convergence in canonical pathways (cell cycle, lysosome, and mTORC1) and less established pathways such as Myc, E2F, and inflammation (IL-6/JAK/STAT3, interferon-γ, TLR signaling, systemic lupus, etc.). Therapeutic trials (adjusted for human drug exposures) showed antitumor activity of cabozantinib. Overall, this study provides insight into MiT/TFE-driven tumorigenesis, including the cell of origin, and characterizes diverse mouse models available for research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAnimalsMiceInfant, NewbornHumansCarcinogenesisCell Transformation, NeoplasticDisease Models, AnimalTranscription FactorsGenomicsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMechanistic Target of Rapamycin Complex 1Translocation, GeneticOncogene Proteins, FusionRNA-Binding Proteins

Stichwörter der Autor:innen

CancerCell biologyMolecular geneticsMouse modelsOncology

Substanzen

Transcription FactorsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMechanistic Target of Rapamycin Complex 1Oncogene Proteins, FusionRBM10 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Kidney Cancer Program, Simmons Comprehensive Cancer Center.
  • Hematology-Oncology Division, Department of Internal Medicine.
  • Peter O' Donnell Jr. School of Public Health.
  • Department of Radiology, and.
  • Quantitative Biomedical Research Center, Department of Population and Data Sciences, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NICHD NIH HHS
  • Department of Defense
  • Joey’s Wings Foundation
  • National Institutes of Health
  • Cancer Prevention and Research Institute of Texas
  • U.S. Department of Defense

Zitieren

APA

Prakasam, G., Mishra, A., Christie, A., Miyata, J., Carrillo, D., Tcheuyap, V. T., Ye, H., Do, Q. N., Wang, Y., Reig Torras, O., Butti, R., Zhong, H., Gagan, J., Jones, K. B., Carroll, T. J., Modrusan, Z., Durinck, S., Requena-Komuro, M. C., Williams, N. S., …, & Brugarolas, J. (2024). Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci170559

Vancouver

Prakasam G, Mishra A, Christie A, Miyata J, Carrillo D, Tcheuyap VT, et al. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis. Journal of Clinical Investigation. 2024. doi:10.1172/jci170559

BibTeX
@article{Prakasam2024,
  author = {Prakasam, Gopinath and Mishra, Akhilesh and Christie, Alana and Miyata, Jeffrey and Carrillo, Deyssy and Tcheuyap, Vanina T and Ye, Hui and Do, Quyen N and Wang, Yunguan and Reig Torras, Oscar and Butti, Ramesh and Zhong, Hua and Gagan, Jeffrey and Jones, Kevin B and Carroll, Thomas J and Modrusan, Zora and Durinck, Steffen and Requena-Komuro, Mai-Carmen and Williams, Noelle S and Pedrosa, Ivan and Wang, Tao and Rakheja, Dinesh and Kapur, Payal and Brugarolas, James},
  title = {Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci170559}
}
Kostenlos starten →